Η ΔΠΙΓΡΑΗ ΣΗ ΘΔΡΑΠΔΙΑ ΜΔ α-λιποϊκο ΟΞΤ ΣΗΝ ΔΠΩΓΤΝΗ ΓΙΑΒΗΣΙΚΗ ΝΔΤΡΟΠΑΘΔΙΑ

Μέγεθος: px

Εμφάνιση ξεκινά από τη σελίδα:

Download "Η ΔΠΙΓΡΑΗ ΣΗ ΘΔΡΑΠΔΙΑ ΜΔ α-λιποϊκο ΟΞΤ ΣΗΝ ΔΠΩΓΤΝΗ ΓΙΑΒΗΣΙΚΗ ΝΔΤΡΟΠΑΘΔΙΑ"

ἐλπίς Σκλαβούνος
6 χρόνια πριν
Προβολές:

1 Η ΔΠΙΓΡΑΗ ΣΗ ΘΔΡΑΠΔΙΑ ΜΔ α-λιποϊκο ΟΞΤ ΣΗΝ ΔΠΩΓΤΝΗ ΓΙΑΒΗΣΙΚΗ ΝΔΤΡΟΠΑΘΔΙΑ Αγάζνο Δπάγγεινο, Πέηξνπ Αιεμάλδξα, Νέκηδαο Ιωάλλεο, Υαηδήο Θεόδωξνο, Παπαληθνιάνπ Υξηζηίλα, Φαξξνύ Άλλα, Σεληνινύξεο Νηθόιανο Α Προπαιδευηική Παθολογική Κλινική και Διδική Νοζολογία, Ιαηρική χολή Πανεπιζηημίου Αθηνών, Γ. Ν. Α. Λαϊκό

2 ΚΤΡΙΟ ΣΟΥΟ Παξαθνινύζεζε ηεο επίδξαζεο ηνπ α-ιηπνϊθνύ (Nevralip ) νμένο ζε αζζελείο κε ζπκπηωκαηνινγία δηαβεηηθήο λεπξνπάζεηαο κεηά ρνξήγεζήο ηνπ γηα 40 εκέξεο ζηε δνζνινγία ηωλ 600 mg κία θνξά εκεξεζίωο αζζελείο (25 αζζελείο κε Γ2 θαη 5 αζζελείο κε Γ1) κε 1/1 αλαινγία αλδξώλ/γπλαηθώλ Μέζνο όξνο ειηθίαο 61.8 ± 11.1 έηε BMI.9 ± 6.2 kg/m 2

3 ΓΔΤΣΔΡΔΤΟΝΣΔ ΣΟΥΟΙ 1. Μέηξεζε γιπθόδεο λεζηείαο θαη ηξηγιπθεξηδίωλ πξηλ θαη κεηά ρνξήγεζεο ηνπ α-ιηπνϊθνύ. 2. Σελ επίδξαζε ζηελ πνηόηεηα δωήο ηωλ αζζελώλ 3. Σελ θαηαγξαθή ηεο ζπλνιηθήο εληύπωζεο

4 ΜΔΣΑΒΛΗΣΔ ΚΤΡΙΟΤ ΣΟΥΟΤ Neuropathy Symptoms Score (NSS). One total Score is calculated from the 5 questions of the questionnaire. The Score ranges from 0 (no neuropathic symptoms) to 10 (the most severe neuropathic symptoms). Subjective Peripheral Neuropathy Screen Questionnaire (SPNSQ) The questionnaire consists of 15 yes/ no (1 / 0) questions regarding the symptoms of their neuropathy. One total Score is calculated by summing the answers to the 15 questions. The score ranges from 0 (no neuropathic symptoms) to 15 (the most severe neuropathic symptoms). DN4 Questionnaire. The questionnaire consists of 10 yes/ no (1 / 0) items regarding the neuropathic pain. One total Score is calculated by summing the answers to the 10 items. The score ranges from 0 (no neuropathic pain) to 10 (the most severe neuropathic pain).

5 Μεηαβιεηέο δεπηεξεπόληωλ ζηόρωλ Fasting Glucose & Triglycerides. Quality of life parameters of patients: Brief Pain Inventory (BPI - Modified SF). The BPI consists of 11 items. The first 4 describe the severity of patients pain, while the other 7 describe the degree to which their pain interferes with common dimensions of feeling and function. The answers to all items range from 0 ( no pain in the case of the first four / no interference in the case of the other 7) to 10 ( pain as bad as you can imagine in the case of the first four / interferes completely in the case of the other 7). Two Scores are calculated: (a) The BPI severity score, which is the mean of the answers to the first 4 items and (b) the BPI interference score, which is the mean of the answers to the last 7 items. Neuropathic Pain Symptom Inventory (NPSI). In the case of NPSI, 6 Scores are calculated: A Total Intensity Score, which ranges from 0 (none) to 100 (worst imaginable), and five scores which correspond to the following dimensions of pain: Burning (superficial) spontaneous pain, Pressing (deep) spontaneous pain, Paroxysmal pain, Evoked pain, Paresthesia/dysesthesia. These five scores range from 0 (none) to 10 (worst imaginable). Sheehan Disability Scale (SDS). SDS includes three self-rated items, which measure impairment in functioning. The scale generates 3 scores: (a) a work disability score, (b) a social life disability score, and (c) a family life disability score. These three scores range from 0 (no disability) to 10 (worst imaginable disability). Patient Global Impression Improvement (PGI-I). In the 2nd Visit, the patient describes his/her condition, compared with how it was before the initiation of the treatment with NEVRALIP, using the following scale: Very much better, Much better, A little better, No change, A little worse, Much worse, Very much worse

6 ΓΔΙΚΣΗ ΤΜΠΣΧΜΑΣΧΝ ΝΔΤΡΟΠΑΘΔΙΑ (NSS) Diagram 1. NSS: Mean ± SD at both Study Visits. Minimum value=0 (no neuropathic symptoms), Maximum value=10 (the most severe neuropathic symptoms). Base: Total sample (N=). Mean difference 2.7, p-value<01

7 ΔΡΧΣΗΜΑΣΟΛΟΓΙΟ ΚΑΣΑΓΡΑΦΗ ΠΔΡΙΦΔΡΙΚΗ ΝΔΤΡΟΠΑΘΔΙΑ (SPNSQ) Diagram 2. Subjective Peripheral Neuropathy Screen Questionnaire Score: Mean ± SD at both Study Visits. Minimum value=0 (no neuropathic symptoms), Maximum value=15 (the most severe neuropathic symptoms). Base: Total sample (N=). Mean difference 4.9, p-value<01

8 ΔΡΧΣΗΜΑΣΟΛΟΓΙΟ DN4 Diagram 3. DN4 Questionnaire Score: Mean ± SD at both Study Visits. Minimum value=0 (no neuropathic pain), Maximum value=10 (the most severe neuropathic pain). Base: Total sample (N=). Mean difference 3.6, p-value<01

9 ΓΔΤΣΔΡΔΤΟΝΣΔ ΣΟΥΟΙ FASTING GLUCOSE Mean median SD Minimum Maximum N Mean difference Visit 1 (baseline) Visit 2 (40 days after) p-value TRIGLYCERIDES Mean median SD Minimum Maximum N Mean difference Visit 1 (baseline) , Visit 2 (40 days after) p-value < 01

10 ΜΔΣΑΒΛΗΣΔ ΓΔΤΣΔΡΔΤΟΝΣΧΝ ΣΟΥΧΝ BRIEF PAIN INVENTORY (BPI) BPI - Pain Severity Minimum value=0 (no pain), Maximum value=10 (pain as bad as you can imagine) Mean median SD Minimum Maximum N Mean difference Visit 1 (baseline) Visit 2 (40 days after) p-value < 01 BPI - Pain Interference Minimum value=0 (no interference), Maximum value=10 (interferes completely) Mean median SD Minimum Maximum N Mean difference Visit 1 (baseline) Visit 2 (40 days after) p-value < 01

11 NEUROPATHIC PAIN SYMPTOM INVENTORY (NPSI) NPSI Total intensity score (10) Minimum value=0 (none), Maximum value=100 (worst imaginable) Mean median SD Minimum Maximum N Mean difference Visit 1 (baseline) Visit 2 (40 days after) p-value < 01 Burning (superficial) spontaneous pain (1) Minimum value=0 (none), Maximum value=10(worst imaginable) Mean Median SD 2, Minimum Maximum N Mean difference 3.0 (p-value <01) Pressing (deep) spontaneous pain (2) Minimum value=0 (none), Maximum value=10(worst imaginable) Mean Median SD Minimum Maximum N Mean difference 1.9 (p-value <01) Paroxysmal pain (2) Minimum value=0 (none), Maximum value=10(worst imaginable) Mean Median SD Minimum Maximum N Mean difference 2.8 (p-value <01) Evoked pain (3) Minimum value=0 (none), Maximum value=10(worst imaginable) Mean Median SD Minimum Maximum N Mean difference 1.3 (p-value <01) Paresthesia/dysesthesia (2) Minimum value=0 (none), Maximum value=10(worst imaginable) Mean Median SD Minimum Maximum N Mean difference 3.2 (p-value <01)

12 SHEEHAN DISABILITY SCALE (SDS)

13 PATIENT GLOBAL IMPRESSION- IMPROVEMENT (PGI-I)

14 ΤΜΠΔΡΑΜΑΣΑ Βειηίωζε ζπκπηωκάηωλ δηαβεηηθήο λεπξνπάζεηαο Βειηίωζε πνηόηεηαο δωήο Μείωζε ηξηγιπθεξηδίωλ

15 ΔΤΥΑΡΙΣΧ!

Σχετικά έγγραφα

ΣΔΥΝΟΛΟΓΙΚΟ ΠΑΝΔΠΙΣΗΜΙΟ ΚΤΠΡΟΤ ΥΟΛΗ ΔΠΙΣΗΜΧΝ ΤΓΔΙΑ ΣΜΗΜΑ ΝΟΗΛΔΤΣΙΚΗ. Πηπρηαθή εξγαζία

ΣΔΥΝΟΛΟΓΙΚΟ ΠΑΝΔΠΙΣΗΜΙΟ ΚΤΠΡΟΤ ΥΟΛΗ ΔΠΙΣΗΜΧΝ ΤΓΔΙΑ ΣΜΗΜΑ ΝΟΗΛΔΤΣΙΚΗ Πηπρηαθή εξγαζία ΣΟ ΑΓΥΟ ΠΟΤ ΒΙΧΝΟΤΝ ΓΟΝΔΙ ΣΗΝ ΦΡΟΝΣΙΓΑ ΑΤΣΙΣΙΚΟΤ ΠΑΙΓΙΟΤ 2-18 ΔΣΧΝ Φξεηδεξίθε Νενθιένπο Λεκεζόο, 2014 ΣΔΥΝΟΛΟΓΙΚΟ ΠΑΝΔΠΙΣΗΜΙΟ